HCW Biologics is trading 6.33% higher at $1.76 amid its announcement of a $1.5 million private placement; the announcement did not explicitly attribute the share-price increase to the offering. - Published on September 24, 2026, the announcement covers a placement with an existing stockholder of 903,614 units priced at $1.6599 each, consisting of pre-funded warrants and potential common warrants. - Proceeds will support clinical trials and development programs.